Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Dec;8(12):1547-57.
doi: 10.2217/fmb.13.127.

Regulation of the life cycle of HPVs by differentiation and the DNA damage response

Affiliations
Review

Regulation of the life cycle of HPVs by differentiation and the DNA damage response

Shiyuan Hong et al. Future Microbiol. 2013 Dec.

Abstract

HPVs are the causative agents of cervical and other anogenital cancers. HPVs infect stratified epithelia and link their productive life cycles to cellular differentiation. Low levels of viral genomes are stably maintained in undifferentiated cells and productive replication or amplification is restricted to differentiated suprabasal cells. Amplification is dependent on the activation of the ATM DNA damage factors that are recruited to viral replication centers and inhibition of this pathway blocks productive replication. The STAT-5 protein appears to play a critical role in mediating activation of the ATM pathway in HPV-positive cells. While HPVs need to activate the DNA damage pathway for replication, cervical cancers contain many genomic alterations suggesting that this pathway is circumvented during progression to malignancy.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Structure of the HPV genome
The linearized HPV31 genome is shown. The replication ori and enhancer are located in the URR. The viral early promoter, later promoter and two polyadenylation sites regulate the expression of three groups of viral genes. E6 and E7 immortalize the host cells and maintain replication competence. E1, E2, E4, E5 and E8 are involved in viral DNA replication, alternation in DNA damage response, suppression of immune response and other functions. L1 and L2 are the two capsid genes. Ori: Origin; URR: Upstream regulatory region.
Figure 2
Figure 2. Life cycle of HPV
HPVs infect keratinocytes in the basal layer of stratified epithelia following exposure through microwounds. (A) A normal uninfected epithelium and (B) a HPV-infected epithelium. Following entry and establishment in the nucleus, viral genomes are replicated in basal cells together with cellular chromosomes. Only a low level of expression of viral genes is observed in infected basal cells and significant levels of viral transcripts are seen in differentiated cells. Upon differentiation, HPV late gene expression and amplification is activated. This is followed by virion assembly, and the newly synthesized virions are shed from the top layers of epithelium.
Figure 3
Figure 3. HPV uses STAT-5 signaling to activate the ATM kinase DNA damage response
STAT-5 has important roles in cell proliferation, apoptosis and differentiation. Normally, the cytoplasmic forms of STAT-5 are phosphorylated upon stimulation with cytokines, such as GM-CSF and IL-6. The activated form of STAT-5 translocates into the nucleus to turn on downstream genes, such as PPARγ. Upon HPV infection, HPV activates STAT-5 in the absence of exogenous cytokines. The phosphorylated STAT-5 induces increased levels of PPARγ in HPV-positive cells, which activates the ATM DNA damage pathway. The ATM DNA damage is necessary for HPV genome amplification. E7 induces activation of ATM, which then turns on downstream effectors, such as BRCA1, CHK2 and p53, leading to cell cycle arrest and HPV amplification. P: Phosphate.

References

    1. Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2(5):342–350. - PubMed
    1. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep. 2007;56(RR-2):1–24. - PubMed
    1. Moody CA, Laimins LA. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer. 2010;10(8):550–560. Describes the critical role of the ATM DNA damage pathway in HPV genome amplification. - PubMed
    1. Harper DM, Franco EL, Wheeler CM, et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet. 2006;367(9518):1247–1255. - PubMed
    1. Wheeler CM, Castellsague X, Garland SM, et al. Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol. 2012;13(1):100–110. - PubMed

Publication types